Testosterone Compound Injection ( Sustanon)

Testosterone Compound Injection ( Sustanon)

  • Packing: 1 Ml Ampoule, 10 Ml Vial, 1 ml PFS
  • Available Strength : 250 Mg/Ml, 400 mg/ml

Description

Product Description: Testosterone Compound Injection, commonly known as Sustanon, is a blend of different testosterone esters designed for intramuscular administration. It contains a mixture of testosterone propionate, testosterone phenylpropionate, testosterone isocaproate, and testosterone decanoate. Sustanon is formulated to provide a sustained release of testosterone over an extended period.

Indications and Usage: Testosterone Compound Injection (Sustanon) is indicated for testosterone replacement therapy in males with conditions associated with deficiency or absence of endogenous testosterone. It is used to treat hypogonadism, androgen deficiency syndromes, delayed puberty, and as hormone therapy for transgender men.

Dosage and Administration: The dosage of Testosterone Compound Injection (Sustanon) varies depending on the patient's age, sex, and specific condition being treated. It is typically administered by intramuscular injection into the gluteal muscle. The recommended dose and frequency should be determined by a healthcare professional based on individual patient needs.

Dosage Forms and Strengths: Testosterone Compound Injection (Sustanon) is available as a clear, colorless solution in vials or ampules. The strength of testosterone esters in each milliliter of solution may vary depending on the manufacturer.

Contraindications: Testosterone Compound Injection (Sustanon) is contraindicated in patients with known hypersensitivity to testosterone or any of the components of the formulation. It should not be used in males with breast or prostate cancer, and in females with breast cancer or pregnancy.

Warnings and Precautions: Before initiating therapy with Testosterone Compound Injection (Sustanon), healthcare providers should evaluate patients for the presence of prostate cancer, breast cancer, cardiovascular disease, hepatic impairment, renal impairment, and other conditions that may be exacerbated by testosterone therapy. Patients should be monitored regularly for signs of virilization, fluid retention, and other adverse effects.

Adverse Reactions/Side Effects: Common adverse reactions associated with Testosterone Compound Injection (Sustanon) include injection site pain, erythema, swelling, and irritation. Other potential side effects may include acne, oily skin, hair loss, gynecomastia, changes in libido, mood swings, and alterations in lipid profiles.

Drug Interactions: Testosterone Compound Injection (Sustanon) may interact with other medications, including anticoagulants, corticosteroids, insulin, and certain antidiabetic agents. Healthcare providers should carefully monitor patients receiving concomitant therapy for potential drug interactions.

Use In Specific Populations Description: Testosterone Compound Injection (Sustanon) is not recommended for use in children, pregnant women, or nursing mothers due to potential adverse effects on fetal development or infant health. It should be used with caution in elderly patients and those with pre-existing medical conditions.

How Supplied/Storage and Handling: Testosterone Compound Injection (Sustanon) is supplied as a solution in vials or ampules. It should be stored at controlled room temperature, protected from light and moisture. Unused portions should be discarded according to local regulations for biohazardous waste disposal.